李应博,何丰. 跨越竞争丛林与范式重构：全球治理改革进程中的疫苗产业创新治理[J]. 科技进步与对策, 2021, 38(24): 67-75.
Li Yingbo,He Feng. Crossing the Jungle of Competition and Paradigm Reconfiguration：Innovative Governance of Vaccine Industry in Global Governance Reform. SCIENCE & TECHNOLOGY PROGRESS AND POLICY, 2021, 38(24): 67-75.
[1] QUAK S,HEILBRON J,MEIJER J. The development of the vaccine industry,1800-present:a historical-sociological field approach[J]. International Journal of Business and Globalisation,2016,17(2):224-242.[2] 联合国全球治理委员会．我们的全球伙伴关系[Ｍ].伦敦：牛津大学出版社，1995.[3] ROSENAU JAMES N, SINGH J P. Information technologies and global politics: the changing scope of power and governance[M].NY: SUNY Press，2002.[4] BARATTA J P. The politics of world federation[M]//World Constitutionalism. Cambridge Scholars Publishing,2004:236-242.[5] 俞可平. 全球治理引论[J]. 马克思主义与现实,2002(1):20-32.[6] 蔡拓. 全球问题与当代国际关系[M]. 天津:天津人民出版社,2002.[7] SEO S N. A theory of global public goods and their provisions[J]. Journal of Public Affairs,2016,16(4):394-405.[8] HIRSHLEIFER J. From weakest-link to best-shot:the voluntary provision of public goods[J]. Public Choice,1983,41(3):371-386.[9] SAMUELSON P A. The pure theory of public expenditure[J]. The Review of Economics and Statistics,1954,36(4):387-389.[10] COASE R H. The problem of social cost[J]. The Journal of Law and Economics,1960,3:1-44.[11] HABERMAS J. The theory of communicative action[M]. Boston:Beacon Press,1984.[12] 埃莉诺·奥斯特罗姆. 公共事务的治理之道:集体行动制度的演进[M].北京：三联书店,2000.[13] JOEL MOKYR. The lever of riches:technological creativity and economic progress[M].New York:Oxford University Press,1990.[14] ARNOLD TOYNBEE. A study of history[M].Thames and Hudson Ltd,1972. [15] DC NORTH, JJ WALLIS. Integrating institutional change and technical change in economic history a transaction cost approach[J].Journal of Institutional & Theoretical Economics, 1984(4):609-624.[16] CHORDA M. Technopolitan strategies: at the edge of an innovation–driven territorial approach[J]. International Journal of Technology Management, 1995, 10(7-8): 894-906.[17] GACKSTATTER S,KOTZEMIR M,MEISSNER D. Building an innovation-driven economy-the case of BRIC and GCC countries[J]. Foresight,2014,16(4):293-308.[18] BRACZYK H J,COOKE P,HEIDENREICH M. Regional innovation systems[M]. London:Routledge,2003.[19] GIBBONS J H,GWIN H L. Technology and governance[J]. Technology in Society,1985,7(4):333-352.[20] 谢尧雯,赵鹏. 科技伦理治理机制及适度法制化发展[J]. 科技进步与对策,2021,38(16):109-116.[21] LUCE J. Mitochondrial replacement techniques:examining collective representation in emerging technologies governance[J]. Journal of Bioethical Inquiry,2018,15(3):381-392.[22] DESCHAMPS J P,NELSON B. Innovation governance[M]. Hoboken,NJ:John Wiley & Sons,Inc.,2012.[23] BECKER-BLEASE J R. Governance and innovation[J]. Journal of Corporate Finance,2011,17(4):947-958.[24] MATTAR Y. Post-industrialism and Silicon Valley as models of industrial governance in Australian public policy[J]. Telematics and Informatics,2008,25(4):246-261.[25] RITTER T,GEMUNDEN H G. Network competence:its impact on innovation success and its antecedents[J]. Journal of Business Research,2003,56(9):745-755.[26] PATN-ROMERO J D,BALDASSARRE M T,RODRGUEZ M,et al. Application of ISO 14 000 to information technology governance and management[J].Computer Standards & Interfaces,2019,65:180-202.[27] 北京市习近平新时代中国特色社会主义思想研究中心. 深刻认识擘画“十四五”时期发展蓝图的理论创新[N]. 经济日报,2020-11-20(1).[28] BEUMER K. Nation-building and the governance of emerging technologies:the case of nanotechnology in India[J]. NanoEthics,2019,13(1):5-19.[29] LOMBARD M,PASTORET P P,MOULIN A M. A brief history of vaccines and vaccination[J]. Rev Sci Tech,2007,26(1):29-48. [30] KATZ I T,WEINTRAUB R,BEKKER L G,et al. From vaccine nationalism to vaccine equity-finding a path forward[J]. The New England Journal of Medicine,2021,384(14):1281-1283.[31] PAVITT K. Sectoral patterns of technical change:towards a taxonomy and a theory[J]. Research Policy,1984,13(6):343-373.[32] PAVITT K. National systems of innovation:towards a theory of innovation and interactive learning[J]. Research Policy,1995,24(2):320.[33] 北大科技园创新研究院.我国疫苗产业发展概况[N].中国高等技术产业导报，2020-06-22(16).[34] JOSEPH R K. Pharmaceutical industry and public policy in post-reform India[M]. Routledge India,2015.[35] NSF. America's investment in the future[R].National Science Foundation，2000.[36] 弗雷德里克·L.努斯鲍姆. 现代欧洲经济制度史[M].罗礼平,秦传安，译. 上海:上海财经大学出版社,2012.[37] HAYEK F. The fatal conceit: the errors of socialism[M].Chicago:University of Chicago Press, 1988.[38] OLSON M. The logic of collective action[M]. Harvard:Harvard University Press,1971.[39] 赵可金. 病毒与权力:新冠肺炎疫情冲击下的世界权威重构[J]. 世界经济与政治,2020(10):30-49,156.[40] ARCHIBUGI D,MICHIE J. The globalisation of technology:a new taxonomy[J]. Cambridge Journal of Economics,1995,19(1):121-140.[41] ORSENIGO L,PAMMOLLI F,RICCABONI M,et al. The evolution of knowledge and the dynamics of an industry network[J]. Journal of Management & Governance,1997,1(2):147-175.[42] BUCHANAN B. A national security research agenda for cybersecurity and artificial intelligence[R]. Center for Security and Emerging Technology,2020.[43] 张新民. 从新冠病毒疫苗研发看我国战略科技力量建设[J]. 中国科学院院刊,2021,36(6):709-715.[44] ARCHIBUGI D, MICHIE J. The globalization of technology: a new taxonomy[J]. CambridgeJournal of Economics,1995,19(1): 121-140.[45] SAKSENA N. Global justice and the COVID-19 vaccine:limitations of the public goods framework[J]. Global Public Health,2021,16(8-9):1512-1521.[46] GEBRE M S,BRITO L A,TOSTANOSKI L H,et al. Novel approaches for vaccine development[J]. Cell,2021,184(6):1589-1603.[47] 王凯.病毒疫苗的研发现状及展望[J].山东大学学报（医学版），2021,59（5）：8-14.[48] 高广文. 疫苗研发:探索新模式[J]. 世界科学,2014(5):29-30,39.
